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Diminished Lymphocyte Adhesion and Alleviation
of Allergic Responses by Small-Molecule- or
Antibody-Mediated Inhibition of L-Selectin Functions
Gertie J. Oostingh1,2,6, Ralf J. Ludwig3,6, Sven Enders4,5,6, Sabine Gru¨ner1, Gesche Harms4,
W. Henning Boehncke3, Bernhard Nieswandt1, Rudolf Tauber4 and Michael P. Scho¨n1,2
Selectins are attractive targets for specific anti-inflammatory therapies. Using human lymphocytes as well as an
L-selectin-transfected pre-B-cell line in dynamic flow chamber experiments, we could demonstrate that the
small-molecule compound efomycine M blocks L-selectin-mediated lymphocyte rolling on sialylated LewisX, an
action that was confirmed by plasmon resonance spectroscopy. Recruitment of naive lymphocytes to peripheral
lymph nodes depends on L-selectin-mediated adhesion to high endothelial venules. We performed intravital
microscopy studying lymphocyte rolling in peripheral lymph nodes and showed a 53% reduction (P¼ 0.0006) of
lymphocyte rolling in mice treated with efomycine M or a function-blocking antibody against L-selectin. In
addition, the number of lymph node-homing T cells was reduced by 460% using either efomycine M or
L-selectin-blocking antibodies. As recruitment of naive lymphocytes is a prerequisite for sensitization in T-cell-
mediated immune reactions and allergic responses, mice were treated with efomycine M or an L-selectin-
specific antibody during contact sensitization with DNFB. After adoptive transfer of corresponding T cells into
non-sensitized recipient mice, the capacity of these cells to induce contact hypersensitivity was significantly
reduced (P¼ 0.0002 and P¼ 0.0001, respectively). Our data demonstrate that it is possible, in principle, to
diminish T-cell-mediated allergic reactions through interference with L-selectin functions during the early
sensitization phase.
Journal of Investigative Dermatology (2007) 127, 90–97. doi:10.1038/sj.jid.5700504; published online 10 August 2006
INTRODUCTION
Leukocyte tethering and rolling along the vessel wall is
mediated by transient adhesive interactions that are essential
for and precede subsequent activation and firm adhesion of
leukocytes to endothelial cells. These interactions are
primarily mediated by selectins (Stoolman, 1989; von
Andrian et al., 1991; Smith et al., 1993; Springer, 1994;
Butcher and Picker, 1996), single-chain transmembrane
adhesion molecules binding to carbohydrate epitopes on
glycoprotein scaffolds (Stoolman, 1989; Varki, 1994; Feizi,
2001; Ley, 2001). Typically, the three members of the
selectin family, E-, P-, and L-selectin, interact with glyco-
proteins bearing the sialylated LewisX (sLeX) moiety or closely
related structures, such as sialylated Lewisa. In addition to
sLex, P- and L-selectin require negative groups on their
ligands such as tyrosine- or glycan-bound sulfate groups, that
is, on GlyCAM-1, CD34, or podocalyxin (Lasky et al., 1992;
Baumhueter et al., 1993; Mebius et al., 1993). Given the
pivotal role of selectins in early events of leukocyte
recruitment to peripheral organs, specific suppression of
selectin-mediated cellular functions may be of great utility for
the treatment of inflammatory disorders such as psoriasis,
rheumatoid arthritis, or inflammatory bowel diseases (Ulbrich
et al., 2003).
L-selectin (CD62L) is only found on hematopoietic cells
and is expressed on most leukocytes, with the exception of a
proportion of memory T cells and natural killer cells (Finger
et al., 1996; Rainer, 2002). L-selectin plays a predominant
role in lymphocyte homing to lymphoid tissues (Stoolman,
1989; Picker and Butcher, 1992). Given that naive and
memory T cells homing to lymph nodes express L-selectin,
whereas memory T cells that home to sites of inflammation
do not express this molecule, there appears to be a functional
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preference for L-selectin in lymph node homing. Lymph
nodes are involved in antigen presentation to T- and B cells,
as a result of which T cells mature into antigen-specific
cytotoxic T cells or memory T cells and B cells into antibody-
producing plasma cells. Lymphocyte homing to the lymph
nodes is, therefore, of utmost importance for induction of
antigen-specific immune responses (von Andrian and Mem-
pel, 2003). It is predicted that L-selectin functions are a
prerequisite for the sensitization of cells within lymph nodes
(Shimada et al., 2003).
We have recently described efomycine M, a small-
molecule macrolide that inhibits P-selectin (CD62P)- and
E-selectin (CD62E)-mediated leukocyte rolling in inflamed
tissues in vivo and alleviates chronic inflammatory skin
changes in two complementary mouse models of psoriasis
(Scho¨n et al., 2002). However, the effect of efomycine M
on L-selectin (CD62L)-mediated responses as well as its
influence on T-cell sensitization was thus far unknown.
We were interested in studying the effect of L-selectin
inhibition on lymphocyte rolling and homing as well as on
the pathogenesis of T-cell-dependent allergic reactions.
Toward this end, we have analyzed L-selectin-mediated
adherence of lymphocytes to sLeX combined with sulfated
tyrosine (sLex/TS-PAA) under shear stress in a dynamic flow
chamber system. L-selectin interactions with sLex/TS-PAA
were also assessed on the molecular level using surface
plasmon resonance (SPR) spectroscopy (VanCott et al., 1992).
In addition, we performed intravital microscopy experiments
in mice, looking at the influence of efomycine M or
L-selectin-specific antibodies on lymphocyte rolling on high
endothelial venules and homing to peripheral lymph nodes.
Moreover, a murine adoptive transfer model was used to
study the effect of L-selectin-mediated lymphocyte adhesion
on the pathogenesis of a T-cell-dependent allergic response.
We show that L-selectin-mediated responses could be
significantly inhibited by efomycine M in vitro and in vivo
and that interference with L-selectin-mediated lymphocyte
adhesion could significantly reduce T-cell-mediated allergic
responses in vivo. These results indicate that it is possible to
therapeutically influence the pathogenesis and clinical out-
come of T-cell-mediated allergic responses at a very early
stage through interference with L-selectin functions by
antibodies or small-molecule compounds.
RESULTS
L-selectin-dependent cell adhesion to sLeX under shear stress
can be inhibited by efomycine M
Approximately 65% of peripheral blood lymphocytes (PBL)
freshly isolated by density-gradient centrifugation expressed
high levels of L-selectin (mean fluorescence intensity 4100),
but neither E- nor P-selectin (Figure 1a, left panel). The
observation that a function-blocking antibody (Mel-14)
directed against L-selectin completely abrogated rolling and
binding of PBL (n¼5 different donors) on a matrix of sLeX and
sulfated tyrosine (sLeX/TS-PAA) under shear flow (150 sec-
onds1) suggested that leukocyte rolling and adhesion in this
system was dependent on L-selectin functions (Figure 1b).
Efomycine M, a novel small-molecule macrolide compound
(Scho¨n et al., 2002), also had a profound and significant
dose-dependent inhibitory effect on leukocyte rolling in this
system, similar to the effect observed with the L-selectin-
blocking antibody (Mel-14). Significant inhibition of PBL
adhesion was observed at concentrations as low as 1 mM
(Po0.001 as compared to untreated controls; Figure 1b).
These findings indicated that efomycine M inhibits L-selectin
functions.
To prove formally that the rolling and binding seen in the
cellular assay was strictly owing to L-selectin, a pre-B-cell
line (NALM-6; Figure 1a, middle panel), which did not
express L-selectin and did not roll or adhere to sLeX/TS-PAA,
was employed. When NALM-6 cells were transfected with
human L-selectin (Figure 1a, right panel) and used in the flow
chamber system, they had acquired a profound capacity to
roll and adhere on the sLeX/TS-PAA matrix (2175 cells/field),
as compared to their mock-transfected counterparts, which
did not adhere (0 cells/field; Figure 1c and d, and Videos S1
and S2). Again, the L-selectin-dependent binding was
significantly inhibited in a dose-dependent manner either
by the L-selectin-blocking antibody or by efomycine M
(Po0.05 at concentrations X1mM; Figure 1c and d, and
Videos S3 and S4).
Complementary experiments showed no increase in the
number of apoptotic or dead cells as determined by flow
cytometry (FC, annexin V binding to phosphatidylserine and
propidium iodide staining of dead cells) after 30 minutes of
incubation with 300 mM efomycine M (the limit of solubility in
this system) at 371C (data not shown). Thus, the inhibition of
L-selectin-mediated adhesion by efomycine M on the cellular
level was not owing to cytotoxic effects or the induction of
apoptosis in lymphocytes (data not shown). As reported
previously (Scho¨n et al., 2002), longer exposure of endo-
thelial cells to efomycine M (up to 10mM) for 72 hours also
did not result in significantly decreased viability or reduced
cell proliferation as compared to untreated control cells. In
addition, as detected by two-color FC, incubation with
efomycine M did not alter the expression of several activation
markers, including CLA, CD25, CD69, CD54, and HLA-DR
on CD3þ T cells (n¼ 6 donors in each case, data not shown),
suggesting that efomycine M did not exert detectable effects
on lymphocyte activation. Moreover, the expression of
L-selectin was not altered after incubation with efomycine
M, indicating that efomycine M did not induce L-selectin
shedding (Figures S1 and S2).
The direct antiadhesive activity of efomycine M toward
L-selectin on the molecular level was confirmed by dynamic
real-time biomolecular interaction analysis, using SPR
technology. Real-time biomolecular interaction analysis
monitors the formation and dissociation of biomolecular
complexes on a sensor surface as the interaction occurs. By
covalently attaching sLeX/TS-PAA to the surface, the interac-
tion of L-selectin present in free solution with the ligand was
followed. Measurements were made under conditions of
continuous flow. It was found that efomycine M had a highly
significant, albeit biphasic, inhibitory effect on L-selectin
adhesion to immobilized sLeX/TS-PAA with inhibition by
approximately 50% at 20 mM (P¼0.0003 compared to
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vehicle control, calculated from data of four independent
experiments; Figure 1e).
Lymphocyte rolling on lymph node vessels and lymph node
homing in vivo is inhibited by small-molecule- or antibody-
mediated inhibition of L-selectin functions
To confirm the inhibitory activity on L-selectin-mediated
adhesion in vivo, the recruitment of lymphocytes to
peripheral lymph nodes was studied, a process that is
critically dependent on L-selectin functions (von Andrian
and Mempel, 2003).
As has been shown previously, efomycine M reaches
maximum serum levels 30 minutes after intraperitoneal
injection, and the elimination half-life of efomycine M is
more than 2 hours (Scho¨n et al., 2002). These kinetics result
in serum concentrations sufficient for in vitro inhibition of
R
el
at
ive
 c
e
ll 
nu
m
be
r
Mean fluorescence intensity
Control Control Control
L-selection
L-selection
L-selection
PBL NALM-6/mock NALM-6/L-selection
60
Bo
un
d 
ce
lls
 (m
ea
n ±
 S
D)
Bo
un
d 
ce
lls
 (m
ea
n ±
 S
D)
40
20
***
*** ***
*** ***
***
***
***
***
***
***0
Ab 0 0.5 2.5 25 50 75 100150 3001051
NS
Vehicle
Efomycine M, (10 M)
140
120
100
80
60
40
20
0
50
R
el
. b
in
di
ng
 (%
 of
 co
ntr
ol)
100 150 200 250 300
Efomycine M (M)
Mock
5
10
15
20
25
Ab 0 1 5 10 25 50 100 300
*** ***
*** ***
***
***
***
**
a
b
d e
c
Figure 1. L-selectin-mediated adhesion in vitro can be inhibited by L-selectin-specific antibody or efomycine M (corresponds to Videos S1–S4). (a) FACS
analysis demonstrating expression of L-selectin in PBL (left panel), mock-transfected NALM-6 cells (middle panel), and NALM-6 cells transfected with human
L-selectin. (b) Rolling of PBL in a dynamic flow chamber system in the presence of a function-blocking mAb directed against L-selectin (mAb Mel-14; column 1)
or various concentrations of efomycine M (in mM) as indicated (***Po0.001 as compared to untreated controls; NS, not significant). This experiment was
repeated three times with similar results in each experiment. (c) Rolling of mock-transfected NALM-6 cells (column 1) and NALM-6 cells transfected with
L-selectin (other columns) in a dynamic flow chamber system in the presence of a function-blocking mAb against L-selectin (column 2) or various
concentrations of efomycine M (in mM) as indicated (*Po0.05, and ***Po0.001 as compared to untreated controls). The experiment was repeated twice.
(d) Microscopic image of NALM-6 cells transfected with L-selectin in a dynamic flow chamber system in the presence of vehicle (DMSO 0.1%; upper panel)
or efomycine M (10 mM, bottom panel). Cell adhesion to a matrix of sLeX/PAA was analyzed at 1.04 dyn/second2. Bar¼ 50 mm. (e) SPR analysis of the binding
of a multimerized L-selectin-IgG chimera to immobilized sLeX/TS-PAA in the presence of the indicated concentrations of efomycine M. SPR was used for
real-time biomolecular interaction analysis under conditions of continuous flow (20 ml/minute). Each data point represents a binding signal relative to the signal
obtained by control measurements (buffer only). Each of the indicated concentrations of efomycine M were measured in four independent experiments.
92 Journal of Investigative Dermatology (2007), Volume 127
GJ Oostingh et al.
L-Selectin Inhibition Reduces Lymphocyte Adhesion
selectin functions for up to 8 hours following a single
injection. In the first series of experiments, intravital
microscopy of peripheral lymph nodes of C57BL6 mice
showed that the addition of efomycine M significantly
reduced the number of fluorescently labeled leukocytes that
rolled along the wall of high endothelial venules of the
subiliac lymph node (Figure 2a and Videos S5 and S6). The
rolling fraction in vehicle-treated control mice (n¼6) was
56.3% (SEM¼ 5.55) as compared to 26.7% (SEM¼3.22) in
efomycine M-treated mice (n¼ 6; P¼0.0006 as compared to
vehicle control) and 31.7% (SEM¼3.31) in mice treated with
a function-blocking antibody against L-selectin (n¼6;
P¼0.02 compared to vehicle control).
To confirm that decreased rolling of lymphocytes along
the lymph node vessel walls was functionally relevant and
resulted in decreased homing, freshly isolated lymph node
cells were fluorescently labeled with the intravital dye PKH26
and injected intravenously into syngeneic recipient mice
(107 cells/mouse). As detected by FC of single-cell suspen-
sions of lymph nodes after 2 hours, labeled cells could be
retrieved from the recipients’ peripheral lymph nodes (0.11%,
SEM¼0.01 in mice treated with vehicle, and 0.11%,
SEM¼0.01 in mice treated with vehicle and an additional
isotype-matched antibody; Figure 2b). Of note, the number
of retrieved cells was dramatically reduced by 72.7% in
mice pretreated with efomycine M (0.03%, SEM¼0.01;
P¼0.0016 as compared to isotype-treated controls) and
by 68.2% in mice treated with an L-selectin-blocking
antibody (0.035%, SEM¼0.005; P¼0.0012 as compared to
isotype-treated controls).
Targeting of L-selectin functions impairs the pathogenesis of
contact hypersensitivity reactions in mice
Several lines of evidence, including the observation that
L-selectin-deficient mice are unable to mount a delayed-type
hypersensitivity response after conventional immunization
(Xu et al., 1996), have indicated that L-selectin-mediated
homing to peripheral lymph nodes is critical for sensitization
of T cells, an essential requirement in the pathogenesis of
allergic responses to contact allergens. Intrigued by our
findings that efomycine M diminished the recruitment of
lymphocytes to peripheral lymph nodes, we have tested the
hypothesis that efomycine M is beneficial for the prevention
of a T-cell-mediated allergic response. Toward this end,
immunocompetent C57BL6 mice were injected intravenously
with a single dose of either vehicle, efomycine M (4 mg/kg) or
an L-selectin-blocking antibody (Mel-14, 4 mg/kg). One hour
thereafter, the mice were subjected to epicutaneous sensiti-
zation with the contact allergen DNFB. In order to avoid a
direct effect of therapeutic compounds on the elicitation
phase of contact hypersensitivity, peripheral lymph node
cells of the sensitized animals were isolated and adoptively
transferred into untreated syngeneic recipients 5 days after
sensitization (5107 cells/mouse, intravenous transfer). The
recipients’ ears were challenged with DNFB immediately
after adoptive transfer of cells.
Average ear swelling responses (expressed as the differ-
ence between thicknesses of vehicle- versus DNFB-chal-
lenged ears) 24 hours after challenge were 0.385 mm in
recipients of lymphocytes from untreated donors (n¼10
mice; SEM¼ 0.0299). In contrast, this response was signifi-
cantly diminished by 56.2% when recipients of cells from
efomycine-treated mice were analyzed (n¼10; average
swelling 0.168 mm; SEM¼0.0258; P¼ 0.0002 as compared
to the vehicle-treated controls; Figure 3a). When recipients of
cells obtained from mice treated with both efomycine M and
the L-selectin-blocking antibody were assessed, no significant
additional effect of antibody-mediated L-selectin inhibition
was observed (n¼10; average swelling 0.147 mm;
SEM¼ 0.0204; P¼0.0001 as compared to controls; Figure
3a). The results were confirmed histopathologically by a
dermatopathologist in a blinded manner and clearly showed
a diminished density of infiltrating immune cells in recipients
of cells from pretreated donors (Figure 3b). In addition,
the dermal edema was markedly weaker in recipients of
cells from efomycine M- or antibody-pretreated donors.
Treatment with efomycine M did not result in significant loss
of L-selectin expression in lymph node lymphocytes under
the conditions used for the adoptive transfer experiments
(Figure S2).
DISCUSSION
Selectins are involved in the recruitment of lymphocytes from
blood vessels to sites of inflammation. However, L-selectin
(CD62L) has another, specific, function in the homing of
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Figure 2. Inhibition of L-selectin-dependent lymphocyte homing in vivo
(corresponds to Videos S5 and S6). (a) Intravital microscopy assessing the
rolling fraction of fluorescently labeled lymphocytes in a lymph node in vivo.
Rolling of fluorescently labeled lymphocytes along the venules of the subiliac
lymph node was visualized by intravital microscopy in untreated mice
(column 1) and after injection of efomycine M (4 mg/kg, column 2) or a
L-selectin-blocking antibody (4 mg/kg, column 3) of the same lymph node
(*Po0.05, **Po0.01, two-tailed t-test as compared to untreated control).
Three vessels of two mice (n¼ 6) were included in this study. The data shown
are representative of three experiments. (b) Homing of fluorescently labeled
lymphocytes to peripheral lymph nodes in the absence (column 2) or
presence of isotype control antibody (column 3), L-selectin-specific antibody
(column 4) or efomycine M (5 mg/kg mouse; column 5), n¼2 for each group.
The analysis was performed in triplicate. **Po0.01 as compared to the
controls.
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lymphocytes to peripheral lymph nodes (Xu et al., 1996; Ley,
2001; Ley and Kansas, 2004). The selectin ligand, 60-sulfo
sialylated LeX is highly expressed in the high endothelial
venules of peripheral lymph nodes and L-selectin preferen-
tially binds to this specific ligand, which contributes to
homing of L-selectin-expressing lymphocytes to lymph nodes
(Hiraoka et al., 1999). This function of L-selectin is of great
clinical importance inasmuch as it is a prerequisite for T-cell
sensitization in the pathogenesis of allergies. The relentless
increase in the prevalence of T-cell-dependent allergic
disorders, such as occupational contact allergies (Andersen,
2003) or atopic dermatitis (Williams, 2005), represents a
major medical problem and highlights the need for effective
preventive strategies. In this light, interference with L-selectin
functions at a very early stage in the pathogenic cascade in
individuals at risk may be beneficial in terms of supporting
strategies of primary prevention (Kutting et al., 2004; Arruda
et al., 2005; Arshad, 2005).
In order to provide a proof-of-principle for the hypothesis
that blocking of L-selectin functions would result in
decreased lymphocyte homing, thereby exerting a preventive
effect toward T-cell-mediated hypersensitivity reactions,
efomycine M, a small-molecule macrolide compound, as
well as L-selectin-specific antibodies were used to inhibit
L-selectin-mediated responses in vitro and in vivo. Using a
novel docking engine, it has recently been predicted that
efomycine M binds stronger to the ligand-binding domain as
compared to the natural ligand sLeX, at least with regard to
E-selectin (Wienrich et al., 2006). Our in vitro results showed
that efomycine M as well as specific antibodies could
significantly inhibit L-selectin-dependent lymphocyte rolling
on a selectin ligand. Based on our intravital microscopy of
peripheral lymph nodes and homing experiments in mice,
both efomycine M and L-selectin-directed antibodies had an
immediate and profound effect on lymphocyte homing to
peripheral lymph nodes. Several explanations for the reduced
numbers of labeled lymphocytes detected in the peripheral
lymph nodes can be delineated: first and most likely, it may
reflect diminished trafficking of lymphocytes through high
endothelial venules; second, it may be owing to increased
emigration of lymphocytes from the lymph nodes, or third,
retention of labeled cells could have occurred in other
organs. However, given that significantly decreased rolling of
lymphocytes in peripheral lymph nodes after treatment with
efomycine M or L-selectin-specific antibodies was observed,
the reduced number of lymphocytes detected within the
lymph nodes after treatment with efomycine M was most
likely caused by reduced trafficking to peripheral lymph
nodes following L-selectin inhibition. Although antibodies
against L-selectin have been used previously to interfere with
peripheral tolerance induction (Bai et al., 2002), and
diminished mast cell recruitment alleviated type-I allergic
reactions in L-selectin-deficient mice (Shimada et al., 2003),
our results for the first time allowed to test the hypothesis that
interference with L-selectin functions by a small-molecule
compound can be employed to interfere with the pathogen-
esis of a T-cell-mediated allergic disorder and to alleviate its
clinical outcome.
Indeed, the results from our adoptive transfer experiments,
in which a potential beneficial effect of functional blocking of
L-selectin for the prevention of a T-cell-mediated allergic
response was tested, indicated that inhibition by an antibody
or a small-molecule compound during the sensitization
phase, that is, a very early event in the generation of allergic
responses, can diminish a T-cell-dependent immune re-
sponse in an experimental model relevant for the pathogen-
esis of allergic disorders. Although expression of selectin
ligands on Langerhans cells has been reported (Ross et al.,
1994), it is not clear if and how these ligands contribute to
T-cell sensitization in vivo since (I) E- and P-selectin are not
expressed in normal HEV and (II) previous studies have
shown that mice deficient for a-1,3-fucosyltransferase VII
(which are characterized by deficient E-, P-, and L-selectin
ligand activity) showed normal Langerhans cell migration to
local lymph nodes following contact sensitization (Erdmann
et al., 2002). In any case, the clinical response to challenge
with the contact allergen in our experiments was significantly
weakened, but not completely abrogated. These observations
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Figure 3. Blocking of L-selectin functions interferes with the pathogenesis
of an allergic response in a mouse model of contact hypersensitivity.
(a) Ear swelling responses (expressed as difference between vehicle- and
DNFB-challenged ears) in a contact hypersensitivity/adoptive transfer model
comparing recipients of lymphocytes from untreated donors (n¼ 14) and
donors treated with efomycine M (n¼ 15) or a combination of efomycine
M and anti-L-selectin (n¼10) during the sensitization phase (**Po0.01,
two-tailed t-test). Three separate experiments were performed and the data
of all experiments was combined. (b) Histopathology showing inflammation
and edema in ear skin of recipients of lymphocytes from untreated donors
(top panel) and donors treated with efomycine M (middle panel) or a
combination of efomycine M and anti-L-selectin (bottom panel) during the
sensitization phase as outlined in the text. Please note reduced density
of infiltrating immunocytes and reduced severity of dermal edema in
recipients of lymphocytes from donors treated with efomycine M or an
L-selectin-directed antibody. Bar¼50 mm.
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are consistent with the known functions of L-selectin, which
is particularly important for lymph node recruitment of naive
lymphocytes, but plays a lesser role for the recruitment of
immune cells to peripheral sites during the elicitation phase
of inflammatory reactions. This notion is supported by a
recent clinical trial in which antibody-mediated blockade of
L-selectin did not alleviate psoriasis, a common inflammatory
skin disorder (Hardtke et al., 2005). In contrast, based on our
experimental evidence, it is conceivable that early inter-
ference with L-selectin functions during the T-cell-dependent
sensitization phase by a small-molecule compound can
alleviate the clinical outcome of an allergic response.
Overall, inhibition of L-selectin-mediated responses using
the small-molecule efomycine M or L-selectin-specific
antibodies can diminish lymphocyte recruitment in vitro
and in vivo.
MATERIALS AND METHODS
Cell preparation, generation of transfectants, and analysis of
surface antigen expression
PBL were isolated from human blood under aseptic conditions by
density-gradient centrifugation (Ficoll-PaqueTM Plus; Amersham
Biosciences, Uppsala, Sweden). PBL were washed twice (340 g
for 5 minutes) in phosphate-buffered saline and resuspended at
2 106 cells/ml in Hank’s balanced salt solution containing 2 mM
CaCl2. Human pre-B cells (NALM-6) were transfected with plasmid
pCR 3.1/L-sel containing the coding sequence of full-length human
L-selectin or, as control, with plasmid pCR 3.1 only (mock-
transfected cells). The cells were cultured in N-2-hydroxyethylpiper-
azine-N0-2-ethanesulfonic acid-buffered Roswell Park Memorial
Institute 1640 medium supplemented with 10% fetal calf serum,
penicillin, streptavidin, and geneticin (used as selection antibiotic).
Cell adhesion under flow conditions
Rectangular coverslips (24 60 mm) were coated with 2.5 or 5.0mg
biotinylated polyacrylamide labeled with 20% (molar ratio) sLeX and
5% (molar ratio) sulfated tyrosine (sLeX/TS-PAA, 30–40 kDa; Lectinity
Holdings Inc., Moscow, Russia). This ligand has previously been
used to analyze L-selectin-mediated interactions and was shown to
have several characteristics in common with natural L-selectin
ligands (Galustian et al., 2002). The cover slips were air-dried and
blocked for at least 1 hour with 0.5% BSA in phosphate-buffered
saline. Cell suspensions in Hank’s balanced salt solution with 2 mM
CaCl2 were incubated for 30 minutes at 371C in the presence or
absence of efomycine M (99.9% pure; kindly provided by T Krahn,
BayerHealthCare, Wuppertal, Germany) at final concentrations
ranging from 0.1 to 300 mM or an L-selectin-blocking antibody
(Mel-14, 10 mg/ml). Transparent flow chambers with a slit depth of
50 mm and a slit width of 5 mm, equipped with coated or uncoated
cover slips, were briefly rinsed with Hank’s balanced salt solu-
tionþ 2 mM CaCl2, and connected to a syringe containing the
preincubated cell suspension. Perfusion was performed at 371C
using a pulse-free pump under low shear stress conditions (flow rate
of 1.12 ml/hour, equivalent to a wall shear rate of 150/seconds).
Microscopic phase-contrast images were recorded in real time. At
least three different microscopic fields were recorded for each
condition. Image analysis was performed off-line using MetaView
Imaging software (Universal Imaging Corporation, Downington, PA).
The number of adhering cells from all three fields was counted and
the mean value (7SD) was used for analysis.
Flow cytometric analysis
Cells were incubated at 41C for 45 minutes with 10 mg/ml of the
primary mAb, washed three times in FC buffer (phosphate-buffered
saline containing 1% BSA and 0.002% NaN3), and incubated with
FITC-conjugated goat anti-mouse IgG for 45 minutes at 41C. The
cells were washed again three times in FC buffer and analyzed using
a fluorescence-activated cell scanner (FACScan, Becton Dickinson,
Heidelberg, Germany) and the Cell Quest software (Becton
Dickinson).
Commercially available murine mAbs against the following
surface antigens were used: CD3, CD25, CD62L, CD54, CD69,
CLA (cutaneous lymphocyte-associated antigen), and HLA-DR.
Isotype-matched murine IgG was used as control (Dako, Hamburg,
Germany). In order to assess whether efomycine M affected cell
surface expression of L-selectin (CD62L), lymphocytes (PBL) were
incubated for 60 minutes with efomycine M at the indicated
concentrations. Thereafter, surface expression of L-selectin was
assessed by FC.
Apoptosis assay
Apoptosis induced by incubating PBL or NALM-6 cells for
30 minutes at 371C with 75 or 300 mM efomycine M was determined
using the commercially available annexin V-FITC apoptosis detec-
tion kit (Sigma, Deisenhofen, Germany) following the manufac-
turer’s instructions.
SPR spectroscopy
SPR experiments were performed on a BIACORE X instrument
(Biacore AB, Uppsala, Sweden) at 251C. Biotinylated sLeX/TS-PAA
(Lectinity) was immobilized on a sensor chip SA (Biacore), whose
surface consists of a carboxymethylated dextran matrix preimmobi-
lized with streptavidin. Biotinylated N-acetyllactosamine-PAA (Lac-
NAc-PAA) was immobilized as reference on a second lane of the
same chip. The loading of the chip with both conjugates was carried
out up to a baseline shift of 900 resonance units (RU), respectively.
Recombinant L-selectin-IgG chimera was produced in the human
myeloid cell line K562 (Harms et al., 2001), purified by affinity
chromatography and used in a multimeric form (2 nM per sample) by
immobilization on Protein A-labeled gold beads (+ 20 nm, Sigma).
Before passing the sensor surface, multimerized L-selectin was
incubated with efomycine M for 18 minutes at room temperature at
final concentrations of 0, 0.1, 10, 20, 100, or 300 mM. Binding was
recorded in running buffer (20 mM N-2-hydroxyethylpiperazine-N0-
2-ethanesulfonic acid, pH 7.4, 150 mM NaCl, 1 mM CaCl2) at a flow
rate of 20 ml/min. Each cycle consisted of a 1-minute waiting period
to monitor the baseline stability, an association phase of 105 sec-
onds, and a dissociation phase of 180 seconds. Regeneration of the
surface was performed by injection of 4 M MgCl2 at 100ml/minute
use for 60 seconds. Two injections of running buffer were carried out
between each sample to check carry-over effects. Data obtained in
the reference lane were subtracted from that obtained in the sLeX/
TS-PAA lane. Responses of the sample injections were extracted
between report points set at injection start (0 second) and the end of
the dissociation phase (285 seconds). Each data point was measured
in quadruplicate and the mean value (7SD) was used for analysis.
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Intravital microscopy of peripheral lymph nodes
All animal experiments were performed according to the institu-
tional guidelines and were approved by the respective governmental
authorities (Regierungspra¨sidium Darmstadt). Intravital microscopy
of peripheral lymph nodes was performed as described (von
Andrian, 1996) with minor modifications. Briefly, C57BL6 mice
were anesthetized by intraperitoneal injection of Ketamin (Schwabe-
Curamed, Karlsruhe, Germany) and Rompun (Bayer, Leverkusen,
Germany), and placed on a homeothermic blanket. The right carotid
artery was prepared microsurgically and a catheter was inserted
downstream into this vessel for injection of rhodamine 6G,
efomycine M (4 mg/kg bodyweight), or Mel-14, a L-selectin-specific
antibody (4 mg/kg). The subiliac (superficial inguinal) LN was
microsurgically dissected and leukocyte interactions with post-
capillary venules were analyzed after staining with rhodamine 6G
using a previously described setup for intravital microscopy (Ludwig
et al., 2004). Rolling fractions were determined as percentages of
rolling cells in relation to the total flux of fluorescent T cells that
passed through a defined venule.
Homing of lymph node cells to peripheral lymph nodes
Peripheral lymph nodes of mice were gently dissociated into single-
cell suspensions in DMEM. The tissue remnants were removed and
the cells were counted. Cells were than stained using the PKH26 red
fluorescent cell linker kit (Sigma) according to the manufacturer’s
instructions. Syngeneic recipient mice received an intraperitoneal
injection of either vehicle (1% DMSO, 5% ethanol, 5% Solutol-
HS15 (BASF), and 89% H2O) or 5 mg/kg efomycine M dissolved in
vehicle. After a 2-hour incubation, 107 stained donor cells were
injected intravenously. The following groups were included in this
analysis: (I) mice treated with vehicle, but without cells (control I),
(II) mice treated with vehicle and cells (control II), (III) mice treated
with vehicle and with cells incubated after staining for 15 minutes
with rat IgG2a isotype control (10mg antibody/107 cells; control III),
(IV) mice treated with vehicle and with cells incubated after staining
for 15-minutes with L-selectin-specific antibody (10 mg antibody/107
cells), and (V) mice treated with efomycine M and cells. The PKH26
red-stained cells were left for 2 hours in the mice before these mice
were killed and the lymph nodes from each individual mouse were
collected, the cells were dissociated and the PKH26 signal was
measured on a FACScan (Becton Dickinson, Heidelberg, Germany).
Induction of contact hypersensitivity and adoptive transfer of
lymph node cells
Donor C57BL6 mice were injected intravenously with either NaCl
(0.9%), efomycine M (4 mg/kg), or the L-selectin-blocking antibody
Mel-14 (4 mg/kg). One hour later, mice were sensitized by painting
75 ml DNFB (Sigma) solution (0.5% in acetone/olive oil, 4/1) on the
back. Peripheral lymph nodes from sensitized mice were removed
on day 5, and single-cell suspensions of donor lymph node cells
(5 107 cells) were injected intravenously into non-sensitized syn-
geneic C57BL6 mice. The recipients were challenged with DNFB
(0.3% in acetone/olive oil, 4/1) immediately thereafter. Twenty-four
hours later, ear-swelling responses were measured in a blinded
manner using a spring-loaded caliper (Mitutoyo, Neuss, Germany).
Ear swelling responses were expressed as difference in ear thickness
in micrometer between DNFB- and solvent-treated ears. In addition,
ears were analyzed histologically in hematoxylin- and eosin-stained
paraffin-embedded tissues by a dermatopathologist in a blinded
manner. Moreover, the contact hypersensitivity model was used to
analyze the effect of treatment with efomycine M on L-selectin
expression in vivo. One group of animals was treated with
efomycine M and one group with vehicle only (n¼ 3 in each group)
and sensitization occurred for 5 days using DNFB. Thereafter,
lymphocytes were isolated from lymph nodes and tested for
L-selectin expression by flow cytometric analysis as described above.
Statistical analysis
All statistical analyses were performed using the Excel software
(Microsoft GmbH, Munich, Germany). Data are displayed as mean
(7SD or SEM as indicated); P-values were determined using the two-
tailed t-test, and P-values o0.05 (confidence interval of 95%) were
considered statistically significant. All statistical tests were two-sided.
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SUPPLEMENTARY MATERIAL
Videos S1–S4. Abrogation of L-selectin-mediated rolling and adhesion under
shear flow by efomycine M or L-selectin-directed antibodies.
Videos S5 and S6. Lymphocyte rolling on lymph node vessels in vivo is
diminished by efomycine M.
Figure S1. Efomycine M does not induce L-selectin shedding in vitro.
Figure S2. Efomycine M does not induce significant L-selectin shedding
in vivo.
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